DNB Carnegie Access: EQL Pharma: Temporary softness in Q2 as visibility recovers – Q2 preview

Modular Finance Ab
2025.10.31 06:43

DNB Carnegie has published a new commissioned research report on EQL Pharma.To access the full report and subscribe to future updates, visit

DNB Carnegie has published a new commissioned research report on EQL Pharma.

To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/

Source: Modular Finance Ab The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer